Skip to main content

Byrne Asset Management LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1911322 KINGSTON, NJ

Position in REGN

as of Jun 30, 2026 · filed Jul 7, 2026
Position Value
$13,717
-$3,281 QoQ
Shares Held
22
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1,204
of 1,322 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Byrne Asset Management LLC holds $220,999 across 8 Biotechnology names. REGN ranks #4 (6.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 REGN
Regeneron Pharmaceuticals, Inc.
This page
22 $13,717

All Filings in REGN

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $13,717 22
2026-03-31 $16,998 22
2025-12-31 $17,753 23
2025-09-30 $12,369 22
2025-06-30 $14,175 27
2025-03-31 $17,124 27
2024-12-31 $24,931 35
2024-09-30 $43,100 41
2024-06-30 $43,092 41
2024-03-31 $39,462 41
2023-12-31 $36,009 41
2023-09-30 $33,741 41
2023-06-30 $29,460 41
2023-03-31 $33,688 41
2022-12-31 $29,581 41
2022-09-30 $33,065 48
2022-06-30 $28,374 48
2022-03-31 $33,524 48
2021-12-31 $34,102 54